Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci
about
Antimicrobial ointments and methicillin-resistant Staphylococcus aureus USA300Evaluation of Synergistic Antibacterial and Antioxidant Efficacy of Essential Oils of Spices and Herbs in CombinationSynergistic antibiofilm efficacy of a gallotannin 1,2,6-tri-O-galloyl-β-D-glucopyranose from Terminalia chebula fruit in combination with gentamicin and trimethoprim against multidrug resistant uropathogenic Escherichia coli biofilmsSynergy and resistance to synergy between beta-lactam antibiotics and glycopeptides against glycopeptide-resistant strains of Enterococcus faecium.Vancomycin-resistant enterococci.Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditisEfficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditisSerum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus speciesCurrent perspectives on glycopeptide resistance.In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations.Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinationsThe VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.Chlorhexidine Induces VanA-Type Vancomycin Resistance Genes in Enterococci.Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci.Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faeciumEvidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital.Genetic basis for vancomycin-enhanced cephalosporin susceptibility in vancomycin-resistant enterococci revealed using counterselection with dominant-negative thymidylate synthase.In Vitro Antibacterial Activity of three Indian Spices Against Methicillin-Resistant Staphylococcus aureus.Genetics and mechanisms of glycopeptide resistance in enterococci.Characterization of vanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147.Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium.Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin.Simple test of synergy between ampicillin and vancomycin for resistant strains of Enterococcus faecium.Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.Enterococcus, an emerging pathogen.Effective bactericidal activity of tobramycin and vancomycin eluted from acrylic bone cement.Isolation and identification of a gallotannin 1,2,6-tri-O-galloyl-β-D-glucopyranose from hydroalcoholic extract of Terminalia chebula fruits effective against multidrug-resistant uropathogens.Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.Synergistic antibacterial and antibiofilm efficacy of nisin in combination with p-coumaric acid against food-borne bacteria Bacillus cereus and Salmonella typhimurium.Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus.Regional limb perfusion in horses.Bactericidal activity of daptomycin against vancomycin-resistant Enterococcus faecium in an in vitro pharmacokinetic model.Antibiotic resistance of Salmonella enterica serovar Typhi in Kolkata, India, and in vitro experiments on effect of combined chemotherapy
P2860
Q24611360-6BC8E203-3C00-4E92-B16A-EAD7A4840D98Q28546001-61DF3CAE-153F-417E-9D6E-E9EC178A80F0Q33745974-509440C4-4388-4165-A710-5E6A05D7043BQ33753174-F1F78F4B-881A-48D9-AE09-F8BBF5BA85E2Q33975592-03D365E4-21B3-40E0-BE24-683C458E0BD8Q33976375-2D762D8F-8AE8-4E6E-A85E-7F77AA93DEE1Q35121434-C6631710-B146-4714-A44C-EEA16058FD4EQ35127818-500FD796-1E19-4AF9-A4D8-C7CAFF9FF9E6Q35368590-61D9737A-B1F1-4906-B6DD-C5DFF8B03FB6Q35746209-4F92C567-11EE-4499-BC70-65A9FB8DAE0CQ35815811-3B17D234-33FB-4994-A636-C4E7429CAE7BQ35821314-6E557056-0AFD-45B3-AA22-98E982503252Q36110967-9F08386E-184B-4057-8F83-11B35F3BC81DQ36730165-812F7648-4B8A-4C5D-80E4-8EEB92BEF168Q36754480-36E1F9C8-5FC5-4ECE-8B73-51B10F8AB3C7Q36757804-8C3358D9-25D8-4F72-8DFF-7DDEC523626DQ36758113-5826EEC8-943E-470C-952A-63AC2D469407Q37242426-B4D9130F-A40F-4C4F-A350-14711E32DA28Q37643711-8957D3F8-4CAB-41EF-99B4-D7AA58AC4FE8Q39088189-4CA89D07-A96A-4C3A-8410-0013FB4874D9Q39866365-E347D13E-3879-41E7-91F2-08949617E60EQ39879697-81769F71-5431-4BC6-A745-599D3B7AD0F5Q39879729-E85B9412-3F4B-4B66-AA8B-578B7B1F0FBDQ40086408-5FD5EC35-3635-43F6-AB0C-0C6E8E2D016EQ40180996-3F5C8A5A-FDF1-417B-9E25-798F58588F9AQ40285110-1522D61F-A116-44C0-AB96-9282B0B20017Q40785841-4A00F86A-BB57-47A8-AFAB-7541D0A569D9Q43692602-7152CE8D-1194-402E-87C3-AB4DAE268985Q43704486-BF7CF7A7-6E6A-48BD-AA91-06C43CD03632Q44579110-1B38BD53-2110-4534-997E-CA497B0A448EQ46908684-E172947A-78C2-4511-B186-268DD19AF28BQ49943901-2C7992B6-ABE5-4227-81F3-E12B5FED2CDCQ51195354-590E95F8-2510-4778-8B7F-40341EDDA510Q53089713-933E2336-EFC0-4039-AB7E-E03657440B41Q54284517-DEE28D59-1EE2-4CAE-9B05-5234FFC7B4E2Q58914912-593CADE4-1D7F-43F6-A6D9-1F47F1F22A51
P2860
Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Effects of combinations of bet ...... opeptide-resistant enterococci
@en
type
label
Effects of combinations of bet ...... opeptide-resistant enterococci
@en
prefLabel
Effects of combinations of bet ...... opeptide-resistant enterococci
@en
P2093
P2860
P356
P1476
Effects of combinations of bet ...... opeptide-resistant enterococci
@en
P2093
Courvalin P
Lambert-Zechovski N
Leclercq R
P2860
P356
10.1128/AAC.35.1.92
P407
P577
1991-01-01T00:00:00Z